Cargando…

Quantifying previous SARS-CoV-2 infection through mixture modelling of antibody levels

As countries decide on vaccination strategies and how to ease movement restrictions, estimating the proportion of the population previously infected with SARS-CoV-2 is important for predicting the future burden of COVID-19. This proportion is usually estimated from serosurvey data in two steps: firs...

Descripción completa

Detalles Bibliográficos
Autores principales: Bottomley, C., Otiende, M., Uyoga, S., Gallagher, K., Kagucia, E. W., Etyang, A. O., Mugo, D., Gitonga, J., Karanja, H., Nyagwange, J., Adetifa, I. M. O., Agweyu, A., Nokes, D. J., Warimwe, G. M., Scott, J. A. G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8548402/
https://www.ncbi.nlm.nih.gov/pubmed/34702829
http://dx.doi.org/10.1038/s41467-021-26452-z
_version_ 1784590565315182592
author Bottomley, C.
Otiende, M.
Uyoga, S.
Gallagher, K.
Kagucia, E. W.
Etyang, A. O.
Mugo, D.
Gitonga, J.
Karanja, H.
Nyagwange, J.
Adetifa, I. M. O.
Agweyu, A.
Nokes, D. J.
Warimwe, G. M.
Scott, J. A. G.
author_facet Bottomley, C.
Otiende, M.
Uyoga, S.
Gallagher, K.
Kagucia, E. W.
Etyang, A. O.
Mugo, D.
Gitonga, J.
Karanja, H.
Nyagwange, J.
Adetifa, I. M. O.
Agweyu, A.
Nokes, D. J.
Warimwe, G. M.
Scott, J. A. G.
author_sort Bottomley, C.
collection PubMed
description As countries decide on vaccination strategies and how to ease movement restrictions, estimating the proportion of the population previously infected with SARS-CoV-2 is important for predicting the future burden of COVID-19. This proportion is usually estimated from serosurvey data in two steps: first the proportion above a threshold antibody level is calculated, then the crude estimate is adjusted using external estimates of sensitivity and specificity. A drawback of this approach is that the PCR-confirmed cases used to estimate the sensitivity of the threshold may not be representative of cases in the wider population—e.g., they may be more recently infected and more severely symptomatic. Mixture modelling offers an alternative approach that does not require external data from PCR-confirmed cases. Here we illustrate the bias in the standard threshold-based approach by comparing both approaches using data from several Kenyan serosurveys. We show that the mixture model analysis produces estimates of previous infection that are often substantially higher than the standard threshold analysis.
format Online
Article
Text
id pubmed-8548402
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-85484022021-10-29 Quantifying previous SARS-CoV-2 infection through mixture modelling of antibody levels Bottomley, C. Otiende, M. Uyoga, S. Gallagher, K. Kagucia, E. W. Etyang, A. O. Mugo, D. Gitonga, J. Karanja, H. Nyagwange, J. Adetifa, I. M. O. Agweyu, A. Nokes, D. J. Warimwe, G. M. Scott, J. A. G. Nat Commun Article As countries decide on vaccination strategies and how to ease movement restrictions, estimating the proportion of the population previously infected with SARS-CoV-2 is important for predicting the future burden of COVID-19. This proportion is usually estimated from serosurvey data in two steps: first the proportion above a threshold antibody level is calculated, then the crude estimate is adjusted using external estimates of sensitivity and specificity. A drawback of this approach is that the PCR-confirmed cases used to estimate the sensitivity of the threshold may not be representative of cases in the wider population—e.g., they may be more recently infected and more severely symptomatic. Mixture modelling offers an alternative approach that does not require external data from PCR-confirmed cases. Here we illustrate the bias in the standard threshold-based approach by comparing both approaches using data from several Kenyan serosurveys. We show that the mixture model analysis produces estimates of previous infection that are often substantially higher than the standard threshold analysis. Nature Publishing Group UK 2021-10-26 /pmc/articles/PMC8548402/ /pubmed/34702829 http://dx.doi.org/10.1038/s41467-021-26452-z Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Article
Bottomley, C.
Otiende, M.
Uyoga, S.
Gallagher, K.
Kagucia, E. W.
Etyang, A. O.
Mugo, D.
Gitonga, J.
Karanja, H.
Nyagwange, J.
Adetifa, I. M. O.
Agweyu, A.
Nokes, D. J.
Warimwe, G. M.
Scott, J. A. G.
Quantifying previous SARS-CoV-2 infection through mixture modelling of antibody levels
title Quantifying previous SARS-CoV-2 infection through mixture modelling of antibody levels
title_full Quantifying previous SARS-CoV-2 infection through mixture modelling of antibody levels
title_fullStr Quantifying previous SARS-CoV-2 infection through mixture modelling of antibody levels
title_full_unstemmed Quantifying previous SARS-CoV-2 infection through mixture modelling of antibody levels
title_short Quantifying previous SARS-CoV-2 infection through mixture modelling of antibody levels
title_sort quantifying previous sars-cov-2 infection through mixture modelling of antibody levels
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8548402/
https://www.ncbi.nlm.nih.gov/pubmed/34702829
http://dx.doi.org/10.1038/s41467-021-26452-z
work_keys_str_mv AT bottomleyc quantifyingprevioussarscov2infectionthroughmixturemodellingofantibodylevels
AT otiendem quantifyingprevioussarscov2infectionthroughmixturemodellingofantibodylevels
AT uyogas quantifyingprevioussarscov2infectionthroughmixturemodellingofantibodylevels
AT gallagherk quantifyingprevioussarscov2infectionthroughmixturemodellingofantibodylevels
AT kaguciaew quantifyingprevioussarscov2infectionthroughmixturemodellingofantibodylevels
AT etyangao quantifyingprevioussarscov2infectionthroughmixturemodellingofantibodylevels
AT mugod quantifyingprevioussarscov2infectionthroughmixturemodellingofantibodylevels
AT gitongaj quantifyingprevioussarscov2infectionthroughmixturemodellingofantibodylevels
AT karanjah quantifyingprevioussarscov2infectionthroughmixturemodellingofantibodylevels
AT nyagwangej quantifyingprevioussarscov2infectionthroughmixturemodellingofantibodylevels
AT adetifaimo quantifyingprevioussarscov2infectionthroughmixturemodellingofantibodylevels
AT agweyua quantifyingprevioussarscov2infectionthroughmixturemodellingofantibodylevels
AT nokesdj quantifyingprevioussarscov2infectionthroughmixturemodellingofantibodylevels
AT warimwegm quantifyingprevioussarscov2infectionthroughmixturemodellingofantibodylevels
AT scottjag quantifyingprevioussarscov2infectionthroughmixturemodellingofantibodylevels